Community/Retail

B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, discusses how quality measures are impacting pharmacy.

At Burmans Pharmacy, the key to extending the spirit of American Pharmacists Month is to continually improve pharmacy operations.

A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules.

When I read a brief article about the 5 traits that make Google CEO Larry Page different from other leaders, I decided to test myself.

The FDA approved Valeant Pharmaceutical International's clindamycin phosphate and benzoyl peroxide 1.2%/3.75% today for the once-daily treatment of both non-inflammatory and inflammatory acne in patients 12 and older.

A student pharmacist wrote an open letter to a radio station after a host disparaged the profession with complaints that ranged from the time he had to wait in line for his Z-Pak medication to the placement of contraceptives near the pharmacy counter, according to Buzzfeed.

Citing a risk of spreading unsuspected cancer, the FDA is advising against the use of laparoscopic power morcellators in the removal of the uterus or fibroids in the majority of women.

The vast majority of patients with chronic kidney disease are recommended to receive statins under current cholesterol management guidelines, but half of those patients are not taking the drugs.

Community chain pharmacies vary in the barriers they face when implementing programs to improve medication therapy management.

The Society for Healthcare Epidemiology of America is dedicated to the prevention of infection in healthcare settings, including the protection of healthcare personnel who provide care to patients with known or suspected Ebola virus disease.

What do lawyers and social workers have in common? According to a new study published in Neurology, these 2 kinds of workers may perform better on cognitive testing in their later years compared with those working in less stimulating jobs.

Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs illegally than teens who have never received a prescription, often by obtaining additional pills from friends or family members.

Amgen has discontinued its studies on rilotumumab in advanced gastric cancer after an increased number of deaths were reported among patients receiving rilotumumab and chemotherapy, compared with those only undergoing chemotherapy.

Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.

B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, discusses new adherence programs independent pharmacists are using.

Megan E. Saunders, PharmD, details the challenges she has encountered in pharmacy school.

Vince Canzanese, RPh, director of compounding at Burmans Pharmacy discusses some of the hot topics at the Brookhaven, Pennsylvania independent pharmacy.

A study from Bristol-Myers Squibb shows a combination of abatacept and methotrexate could help slow the disease progression of rheumatoid arthritis.

Two Rite Aid employees in Moultrie, Georgia, have been accused of stealing prescription medications from their own pharmacy, according to the Moultrie Observer.

No more missed doses with innovative pill bottle.

Networking is one of the most important aspects to ensure your success in pharmacy.

Patients with bipolar disorder who are treated with lithium have a higher risk for long-lasting kidney damage and thus require rigorous monitoring.

Clinical practice guidelines for the diagnosis and treatment of certain types of cancer are surprisingly unstandardized.

Baxter International, Inc, is voluntarily recalling 1 lot of its highly concentrated potassium chloride injection due to mislabeling.

Vitamin D deficiencies are causally associated with increased mortality rates.

Johnson & Johnson announced today a global partnership with Save the Children that has the potential to help millions of children over the next three years.

The FDA has granted orphan drug designation to a treatment for a rare disease that primarily affects kidney function.

Improved patient access to medications and fewer patent expirations will result in a 30% increase in global drug spending, to $1.3 trillion, over the next 5 years.